Reprograming human glioma cells so as to convert them into terminally differentiated neuron-like cells in both culture and in adult mouse brain was demonstrated via expression of a TF functioning in neurogenesis, neurogenin 2 (NGN2), in synergy with SOX11.54 This evidence concerns the gene NEUROG2 and central nervous system cancer.